DOJ’s antitrust case v. Google, new bank-capital and internet-ad rules and a 3M earplug trial appeal are key 2H catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other catalysts. In tech, the Microsoft-Activision M&A will probably close, despite a possible pending FTC appeal, and SCOTUS likely takes a case that shapes internet regulation. In financials, UBS may be fined over RMBS and Credit Suisse’s Archegos failings. In crypto, Coinbase’s defense will be helped by the SEC v. Ripple ruling, and we expect a decision in Grayscale v. SEC.
In health care, DOJ v. Teva goes to trial, as does Exelixis v. MSN. CMS releases Part D drugs subject to negotiation and a drug-pricing demo is possible.

See omnystudio.com/listener for privacy information.

The prescription drug negotiation provisions in the Inflation Reduction Act grant the Medicare agency significant regulatory authority to lower prices for high-expenditure drugs, but there’s a high degree of uncertainty as to how the law will impact generic and biosimilar competition, according to Craig Burton, senior vice president of the Association for Accessible Medicines. Burton joins Bloomberg Intelligence analysts Duane Wright and Letitia Walker on this episode of the Votes and Verdicts podcast to discuss the potential impact of drug-pricing negotiation provisions and the Part D redesign on research and marketing strategies for the generic and biosimilar industry. Burton also shares his views on drug shortages and key pillars for industry. 

See omnystudio.com/listener for privacy information.

Litigation risks continue for manufacturers of PFAS, including 3M, DuPont, Chemours and others, despite 3M’s proposed class action settlement announced in June for $10.5-$12.5 billion and DuPont and Chemours’ deal for $1.2 billion. In this Votes and Verdicts podcast episode, leading remediation technology expert Scott Wilson of Regenesis, a global leader in environmental technology, joins Bloomberg Intelligence analyst Holly Froum to discuss risks that remain and potential impacts of anticipated PFAS regulations.

See omnystudio.com/listener for privacy information.

A major legal hurdle -- the First Amendment – stands between lawmakers’ rhetoric and the reality of a TikTok ban. The app’s rocky congressional hearing in March led some Wall Street analysts to set the chances of a US ban at 80% or higher. In this episode of Votes and Verdicts, Jameel Jaffer, Executive Director of the Knight First Amendment Institute at Columbia University, and a leading US free-speech thinker, joins Bloomberg Intelligence Litigation and Policy Analyst Matt Schettenhelm to discuss why a US ban would be so difficult to impose.

See omnystudio.com/listener for privacy information.

Artificial intelligence regulations, a 3M PFAS contamination trial and FTC antitrust review of Pfizer-Seagen are likely be headline topics in June. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation senior analyst Elliott Stein, gathers the team to discuss these and other catalysts: Duane Wright on the debt ceiling deal and the Medicaid renewal impact on health insurers. Matt Schettenhelm on potential AI regulations and an underappreciated legal threat to Uber and Lyft in California. Holly Froum on the 3M PFAS trial and an appeal argument in Bayer Roundup litigation. Jen Rie and the antitrust implications of the Pfizer-Seagen deal and a preview of an Apple App Store antitrust class action hearing. Nathan Dean on potential restrictions on banker bonuses and Stein on the Supreme Court’s pending ruling on President Biden’s student loan forgiveness plan.

See omnystudio.com/listener for privacy information.

There’s been a shift in investing behavior in the energy space, along with a challenging infrastructure environment. In this Votes and Verdicts podcast episode, Adamantine Energy Director of Sustainable Investment Katie Bays joins Bloomberg Intelligence analyst Brandon Barnes for an in-depth discussion about investing in the energy transition. Bays also talks about permitting reform, electrolyzers and the Nebraska state soft drink.

See omnystudio.com/listener for privacy information.

The prescription drug negotiation provisions in the Inflation Reduction Act fulfill a long-standing policy goal for Democrats and grant the Medicare agency significant regulatory authority to lower prices for high-expenditure drugs, according to Margaux Hall, a partner in the health-care regulatory group at Ropes & Gray. Hall joins Bloomberg Intelligence analysts Duane Wright and Letitia Walker on this episode of the Votes and Verdicts podcast to discuss the potential impact of drug-pricing negotiation provisions on research and development and patient access to innovative therapies. Hall also shares her views on the possible effect for generic manufacturers and the influence of IRA pricing on non-Medicare markets.

See omnystudio.com/listener for privacy information.

The current debt-ceiling talks are part of a broader effort needed by policymakers to address Washington’s fiscal climate that should include entitlement spending, according to Bill Hoagland, senior vice president for the Bipartisan Policy Center. Hoagland joins Bloomberg Intelligence analysts Duane Wright and Nathan Dean on this episode of the Votes and Verdicts podcast to discuss the debt limit, negotiations on how to raise it and how the US amassed $31 trillion in debt. Hoagland worked on Capitol Hill for 25 years for Senate Majority Leader Bill Frist and Budget Committee Chairman Pete Domenici.

See omnystudio.com/listener for privacy information.

How will the prosecution of former President Donald Trump play out? What are the strengths of the indictment? What defenses can we expect? Daniel Horwitz, partner and chair of the litigation department and white-collar defense and investigation practice at McLaughlin & Stern, joins Bloomberg Intelligence analysts Elliott Stein and Nathan Dean on this episode of the Votes and Verdicts podcast to discuss the Manhattan district attorney’s prosecution of Trump. Horwitz worked in the DA’s office for about 10 years and is a seasoned white-collar defense lawyer, enabling him to offer very smart analysis of how the case will play out. Along the way, Horwitz talks about the importance of the Manhattan DA’s office and why “The Last Waltz” is one of the three albums he would want if stranded on a desert island.

See omnystudio.com/listener for privacy information.

Jason Gottlieb, Partner and Chair of the digital assets practice at Morrison Cohen, discusses the future of crypto policy and law in depth with Bloomberg Intelligence analysts Elliott Stein and Nathan Dean, on this episode of the Votes and Verdicts podcast, including the paradigm shift that SEC Chair Gary Gensler is missing, and the type of legislation he’d like to see passed. Gottlieb also talks about the the securities vs. commodities classification and the Major Questions Doctrine.

See omnystudio.com/listener for privacy information.